glp 1 gip 2ra Designing a dual GLP-1R/GIPR agonist from tirzepatide | DDDT Two incretin hormones GLP-1 and

Accessed: 2024-12-07

Pederson RA, Brown JC

Addressing root causes: Unlike medications that simply lower blood sugar, weight loss addresses the excess weight that contributed to developing diabetes in the first place

Most are mild, but some can be serious

Conclusions and Relevance GLP-1 RA therapy in IIH is associated with significant reductions in medication use, symptoms/signs, and procedural interventions, suggesting its potential as a management strategy

Smith C, Patterson-Cross R, Woodward O et al (2022) A comparative transcriptomic analysis of glucagon-like peptide-1 receptor- and glucose-dependent insulinotropic polypeptide-expressing cells in the hypothalamus